Chardan’s 4th Annual Metagenomics and Microbiome Medicines Summit - Virtual
March 1, 2022

On March 1, 2022, Chardan virtually hosted its 4th Annual (and now expanded) Metagenomics and Microbiome Medicines Summit (CMMMS 2022). Replays of sessions, plus a variety of resources, may be requested by emailing corpaccess@chardan.com. CMMMS 2022 featured 14 public and private companies, across subsegments of the metagenomics and microbiome space (e.g., live biotherapeutic products, functional modulators, diagnostics, and contract development and manufacturing.):

• 4D Pharma
• Arbor Bio
• Armata
• Arranta Bio
• Biomx
• Eligo Biosciences
• Finch
• Locus Biosciences
• Metagenomi
• Microbiotica
• Seres Therapeutics
• SNIPR Biome
• Synlogic
• Vedanta Biosciences

**This event is for current or prospective relationships of Chardan. If you would like to request more information contact corpaccess@chardan.com.